SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) ...

Get Instant Summarized Text (Gist) 3D-printed tumor models replicating human tissue properties have been developed to improve the testing of surgical imaging agents.